N-Acetylcysteine Reverses Mitochondrial Dysfunctions and Behavioral Abnormalities in 3-Nitropropionic Acid-Induced Huntington’s Disease

Publisher： Karger

E-ISSN： 1660-2862|9|3|145-157

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.9, Iss.3, 2012-02, pp. : 145-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondrial Inhibitor Models of Huntington’s Disease and Parkinson’s Disease Induce Zinc Accumulation and Are Attenuated by Inhibition of Zinc Neurotoxicity in vitro or in vivo

By  

Neurodegenerative Diseases, Vol. 11, Iss. 1, 2012-05 ,pp. : 49-58

Karger

Access to resources Recommend Favorite

Transcriptional abnormalities in Huntington disease

By Sugars K.L.   Rubinsztein D.C.  

Trends in Genetics, Vol. 19, Iss. 5, 2003-05 ,pp. : 233-238

Elsevier

Access to resources Recommend Favorite

Huntington’s Disease – New Perspectives Based on Neuroendocrine Changes in Rodent Models

By  

Neurodegenerative Diseases, Vol. 6, Iss. 4, 2009-06 ,pp. : 154-164

Karger

Access to resources Recommend Favorite

Pcaf Modulates Polyglutamine Pathology in a Drosophila Model of Huntington’s Disease

By  

Neurodegenerative Diseases, Vol. 9, Iss. 2, 2011-09 ,pp. : 104-106

Karger

Access to resources Recommend Favorite

Impaired Brain Creatine Kinase Activity in Huntington’s Disease

By  

Neurodegenerative Diseases, Vol. 8, Iss. 4, 2010-12 ,pp. : 194-201

Karger

Access to resources Recommend Favorite